Unleashing Canine Superpowers - Cancer Screening That Doesn't Feel Like a Chore

About this session

What if the most sensitive Stage I cancer test on Earth isn't a lab assay — it's a dog's brain, decoded by AI? Dogs have been smelling cancer for decades; we taught AI to read what they smell. At Dognosis, we've built a clinically validated cancer screen by combining trained detection dogs, brain-computer interfaces, and a neural network that translates canine olfaction into digital diagnoses - 90.6% Stage I sensitivity, 91.3% specificity, peer-reviewed across 3,000 patient samples and roughly 5x more sensitive than liquid biopsy. The talk will walk through the technical stack (BCI hardware → EEG signal → neuroAI translation), the clinical pathway from canine signal to confirmed diagnosis, and the business model for at-home cancer screening at a price point that doesn't bankrupt patients. If you build AI for healthcare, work on multi-modal sensing, or want to see neuroAI deployed in the real world, this is the session.